Dannex Ayrton Starwin Plc's latest marketcap:
As of 07/19/2026, Dannex Ayrton Starwin Plc's market capitalization has reached $2.93 M. According to our data, Dannex Ayrton Starwin Plc is the 47499th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 2.93 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | 0 |
| Shares Out | 84.77 M |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | n/a |
Dannex Ayrton Starwin Plc's yearly market capitalization.
| Date | Market Cap | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/19/2026 | 32.21 M | $2.93 M | 7.89% | 47499 |
| 12/31/2025 | 32.21 M | $2.85 M | 0% | n/a |
| 12/27/2024 | 32.21 M | $2.2 M | -5% | n/a |
| 12/22/2023 | 33.91 M | $2.85 M | 0% | n/a |
| 12/29/2022 | 33.91 M | $3.48 M | 0% | n/a |
| 12/15/2021 | 33.91 M | $5.6 M | n/a |
Company Profile
Dannex Ayrton Starwin Plc manufactures and sells pharmaceutical products in Ghana.
It offers a range of products in various categories, such as analgesics and antipyretics, hematinics, anti-tussives, anti-convulsing and anti-asthmatics, cough preparations, dermatological products, food supplements, vitamins, and minerals.
The company manufactures its products in form of syrups, tablets, creams, suspensions, disinfectants, lozenges, powders, capsules, and emulsions.
It provides its products under the Durol, Virol, Samalin, Teeder, Koffex, ORS, Rapinol, Asmadrin, and Milk of Magnesia names.
The company offers its products through wholesalers, pharmacies, and licensed OTC sellers to hospitals, clinics, regional health directorates, and regional medical stores.
Dannex Ayrton Starwin Plc was founded in 1964 and is based in Accra, Ghana.
Frequently Asked Questions
-
What is Dannex Ayrton Starwin Plc's (GHSE-DASPHARMA) current market cap?As of 07/19/2026, Dannex Ayrton Starwin Plc (including the parent company, if applicable) has an estimated market capitalization of $2.93 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Dannex Ayrton Starwin Plc (GHSE-DASPHARMA) rank globally by market cap?Dannex Ayrton Starwin Plc global market capitalization ranking is approximately 47499 as of 07/19/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.